The cause of invasive cervical cancer could be multifactorial

Biomedicine and Pharmacotherapy

Volumn 54, Issue 1, 2000, Pages 54-59

  Haverkos, H ^a,c   Rohrer, M ^b   Pickworth, W ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NIDA Addiction Research Center   (United States)

^c HFD 530 ^*  (United States)

Author keywords

Cervical cancer; Human papillomavirus; Tars

Indexed keywords

TAR;

ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CARCINOMA IN SITU; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA VIRUS; EPIDEMIOLOGICAL DATA; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PERSONAL HYGIENE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TOBACCO; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0034143324     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)88642-4     Document Type: Article

References (47)

1. Munoz N, Bosch FX, Shah NV, Meheus A, eds. The epidemiology of cervical cancer and human papilloma virus. Lyon, France: WHO, IARC Scientific Publication No. 119; 1992.
2. Cervical cancer. NIH Consensus Statement. NIH Consensus Conference April 1-3, 1996 ; 14 : 1-29.
3. Herrero R. Epidemiology of cervical cancer. J Natl Cancer Inst Mono 1996 ; 21 : 1-6.
4. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinos and non-Latinos in Los Angeles county. J Natl Cancer Inst 1986 ; 77 : 1063-77.
5. Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomark Prev 1996 ; 5 : 541-8.
6. Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer; 1987.
7. Armstrong BK, Munoz N, Bosch FX. Epidemiology of cancer of the cervix. In: Coppleson M, ed. Gynecologic Oncology. 2nd Ed. Edinburgh: Churchill Livingstone; 1992. p. 11-28.
8. Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virologic study. Lancet 1986; 2: 237-40.
9. Hoskins WJ, Perez CA, Young RC. Gynecologic tumors. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 4th Ed. Phildelphia: J.B. Lippincott; 1993. p. 1152-225.
10. Linder J. A decade has passed... Am J Clin Path 1997 ; 108 : 492-8.
11. Gissmann L, zur Hausen H. Human papilloma viruses: Physical mapping and genetic heterogeneity. Proc Natl Acad Sci USA 1976; 73: 1310-3.
12. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckman AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia, grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272-8.
13. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
14. Bosch FX, Munoz N, De Sanjose S, Izarzugaza I, Gili M, Viladiu P, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750-8.
15. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
16. Menczer J, Leventon-Kriss S, Modan M, Oelsner G, Gerichter CB. Antibodies to herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel. J Natl Cancer Inst 1975; 55: 3-6.
17. Mendis LN, Best JM, Banatvala JE. Class-specific antibodies (IgG and IgA) to membrane antigens of herpes simplex type-2 infected cells in patients with cervical dysplasia and neoplasia. Int J Cancer 1981; 27: 669-77.
18. Frenkel N, Roizman B, Cassai E, Nahmias A. A DNA fragment of herpes simplex and its transcription in human cervical cancer tissue. Proc Nat Acad Sci USA 1972; 69: 3784-9.
19. Hildesheim A, Mann V, Brinton LA, Szklo M, Reeves WC, Rawls WE. Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991; 49: 335-40.
20. Tornesello ML, Buonaguro FM, Beth-Giraldo E, Giraldo G. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 1993; 36: 57-64.
21. Sun X-W, Kuhn Ellerbrock TV, Chiasson MA, Bush TJ, Wright Jr TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 1343-9.
22. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD, et al. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998; 12: 1459-64.
23. Centers for Disease Control and Prevention. HIV/Surveillance Report, Year-End Editions, 1993-1997.
24. Layde PM, Winkelstein Jr W. Smoking and cervical cancer: Cause or coincidence [letter]. JAMA 1989; 261: 1631-2.
25. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987; 47: 1706-11.
26. Slattery ML, Robison LM, Schuman KL, French TL, Stat M, Abbott TM. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989; 261: 1593-8.
27. Winkelstein Jr. W. Smoking and cervical cancer - Current status: A review. Am J Epidemiol 1990; 131: 945-57.
28. Hoffman D, Hoffman I. The changing cigarette 1950-1995. J Toxicol Environ Health 1997; 50: 307-64.
29. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997; 89: 868-73.
30. Fairley CK, Tabrizi SN, Gourlay SG, Chen S, Borg A, Garland AM. A cohort study comparing the detection of HPV DNA from women who stop smoking and continue to smoke. Aust NZ Obstet Gynaecol 1995; 35: 181-5.
31. Lombard HL, Potter EA. Epidemiological aspects of cancer of the cervix. II. Hereditary and environmental factors. Cancer 1950; 3: 960-8.
32. Rotkin ID. Epidemiology of cancer of the cervix. 3. Sexual characteristics of a cervical cancer population. Am J Public Health Nations Health 1967; 57: 815-29.
33. Zhang J, Thomas AG, Leybovich E. Vaginal douching and adverse health effects: A meta-analysis. Am J Public Health 1997; 87: 1207-11.
34. National Cancer Institute. Surveillance, Epidemiology, and End Results. Online: < http://www-seer.ims.nci.nih.gov > (January 4, 1999).
35. Chacko MR, Mcgill L, Johnson TC, Smith PB, Nenney SW. Vaginal douching in teenagers attending a family planning clinic. J Adolesc Health Care 1989; 10: 217-9.
36. Peritz E, Rancharan S, Frank J, Brown WL, Huang S, Ray R. The incidence of cervical cancer and duration of oral contraceptive use. Am J Epidemiol 1977; 106: 462-9.
37. Brinton LA, Huggins GR, Lehman HF, Mallin K, Savitz DA, Trapido E, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38: 339-44.
38. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: The Maryland cervical cancer case-control study. Am J Epidemiol 1987; 126: 592-604.
39. Slattery ML, Overall JC, Abbott TM, French TK, Robison LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: Support for a sexually transmitted disease hypothesis. Am J Epidemiol 1989; 130: 248-58.
40. Parassini F, La Vecchia C, Negri E, Franceschi S, Moroni S, Chatenoud L, et al. Case-control study of oestrogen replacement therapy and risk of cervical cancer. Br Med J 1997; 315: 85-8.
41. Slattery ML, Abbott TM, Overall Jr JC, Robison LM, French TK, Jolles C, et al. Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology 1990; 1: 8-15.
42. Palan PR, Mikhail MS, Goldberg GL, Basu J, Runawicz CD, Romney SL. Plasma levels of beta-carotene, lycopene, canthaxantihin, retinol, and alpha- and gamma-tocopherol in cervical intraepethelial neoplasia and cancer. Clin Cancer Res 1996: 181-5.
43. Rous P, Kidd JG. The carcinogenic effect of a papilloma virus on the tarred skin of rabbits: I. Description of the phenomenon. J Exp Med 1938; 67: 399-428.
44. Rogers S, Rous P. Joint action of a chemical carcinogen and a neoplastic virus to induce cancer in rabbits: Results of exposing epidermal cells to a carcinogenic hydrocarbon at time of infection with the Shope papilloma virus. J Exp Med 1951; 93: 459-88.
45. Tanaka S, Southam CM. Joint action of herpes simplex virus and 3-methylchoanthrene in production of papillomas in mice. J Natl Cancer Inst 1965; 34: 441-51.
46. Salaman MH, Rowson EK, Roe FJC, Ball JK, Harvey JJ, DeBenedictis G. The combined action of viruses and other carcinogens. In: Viruses, nucleic acids, and cancer. Proceedings of the 17th Annual Symposium on Fundamental Cancer Research, University of Texas, M.D. Anderson Hospital and Tumor Institute. Baltimore: Williams & Wilkins; 1963. p. 544-58.
47. Pott P. Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures and the mortification of the toes and feet. London, 1775. Reprinted in National Cancer Institute Monograph 1963; 10: 7-13.